The results of molecular relapses treatment in acute promyelocytic leukemia (APL) patients.

被引:0
|
作者
Shuravina, EN [1 ]
Parovitchnikova, EN [1 ]
Demidova, IA [1 ]
Olshanskaia, YV [1 ]
Misiurin, AV [1 ]
Savchenko, VG [1 ]
机构
[1] Russian Natl Ctr Hematol, Hematol & Bone Marrow Transplantat Dept, Moscow, Russia
关键词
D O I
10.1182/blood.V106.11.4499.4499
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4499
引用
收藏
页码:203B / 203B
页数:1
相关论文
共 50 条
  • [21] Recent Results of the French Belgian Swiss Acute Promyelocytic Leukemia (APL) Group
    Ades, L.
    Fenaux, P.
    ANNALS OF HEMATOLOGY, 2011, 90 : S45 - S48
  • [22] Clinical Characteristics and Outcomes In Patients With Acute Promyelocytic Leukemia (APL) and Hyperleukocytosis
    Daver, Naval
    Kantarjian, Hagop M.
    Faderl, Stefan H.
    Garcia-Manero, Guillermo
    O'Brien, Susan
    Ferrajoli, Alessandra
    Verstovsek, Srdan
    Popat, Uday
    Hosing, Chitra M.
    Kadia, Tapan M.
    Cortes, Jorge E.
    Ravandi, Farhad
    Anderlini, Paolo
    BLOOD, 2013, 122 (21)
  • [23] ACUTE PROMYELOCYTIC LEUKEMIA - RESULTS OF TREATMENT BY DAUNORUBICIN
    BERNARD, J
    WEIL, M
    BOIRON, M
    JACQUILLAT, C
    FLANDRIN, G
    GEMON, MF
    BLOOD, 1973, 41 (04) : 489 - 496
  • [24] Extramedullary disease in acute promyelocytic leukemia in "Latino" patients.
    Samanez, C
    Santillana, S
    Villanueva, M
    Leon, J
    Wachtel, A
    Ferreyros, G
    Vallejos, C
    Casanova, L
    BLOOD, 2002, 100 (11) : 255B - 256B
  • [25] ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL ASPECTS AND RESULTS OF TREATMENT IN 62 PATIENTS
    PETTI, MC
    AVVISATI, G
    AMADORI, S
    BACCARANI, M
    GUARINI, AR
    PAPA, G
    ROSTI, GA
    TURA, S
    MANDELLI, F
    HAEMATOLOGICA, 1987, 72 (02) : 151 - 155
  • [26] Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)
    G Garcia-Manero
    HM Kantarjian
    S Kornblau
    E Estey
    Leukemia, 2002, 16 : 1888 - 1888
  • [27] Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL)
    Garcia-Manero, G
    Kantarjian, HM
    Kornblau, S
    Estey, E
    LEUKEMIA, 2002, 16 (09) : 1888 - 1888
  • [28] Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL
    Rego, Eduardo M.
    Kim, Haesook T.
    Ruiz-Argueelles, Guillermo J.
    Undurraga, Maria Soledad
    Uriarte, Maria del Rosario
    Jacomo, Rafael H.
    Gutierrez-Aguirre, Homero
    Melo, Raul A. M.
    Bittencourt, Rosane
    Pasquini, Ricardo
    Pagnano, Katia
    Fagundes, Evandro M.
    Chauffaille, Maria de Lourdes
    Chiattone, Carlos S.
    Martinez, Lem
    Meillon, Luis A.
    Gomez-Almaguer, David
    Kwaan, Hau C.
    Garces-Eisele, Javier
    Gallagher, Robert
    Niemeyer, Charlotte M.
    Schrier, Stanley L.
    Tallman, Martin
    Grimwade, David
    Ganser, Arnold
    Berliner, Nancy
    Ribeiro, Raul C.
    Lo-Coco, Francesco
    Loewenberg, Bob
    Sanz, Miguel A.
    BLOOD, 2013, 121 (11) : 1935 - 1943
  • [29] THE IMMUNOPHENOTYPE OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) - AN ECOG STUDY
    PAIETTA, E
    ANDERSEN, J
    GALLAGHER, R
    BENNETT, J
    YUNIS, J
    CASSILETH, P
    ROWE, J
    WIERNIK, PH
    LEUKEMIA, 1994, 8 (07) : 1108 - 1112
  • [30] Prophylactic intrathecal chemotherapy in acute promyelocytic leukemia (APL)
    F Ravandi
    Leukemia, 2004, 18 : 879 - 880